CAS RN: 1396841-57-8
RGFP966
Product Availability
Choose a grade to view its available package options.
4 package records 3 with current stock 1 grade group
Grade
≥98% (4)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250428
100mg
Out of stock
Inquiry
Batchno.20260321
25mg
In stock
Inquiry
Batchno.20250324
5mg
In stock
Inquiry
Batchno.20250728
5mg / 25mg / 100mg / 250mg
Confirm by inquiry
Shanghai, Shandong, Guangdong Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1396841-57-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥97%
0
Out of Stock
Beijing
Inquiry
1396841-57-8 / (E)-N-(2-amino-4-fluorophenyl)-3-[1-[(E)-3-phenylprop-2-enyl]pyrazol-4-yl]prop-2-enamide
Standard CAS: 1396841-57-8
Multi CAS: No
Basic Information
copy
CAS
1396841-57-8 copy
Multi CAS
No copy
Molecular Formula
C21H19FN4O copy
Molecular Weight
362.400000 copy
Exact Mass
362.154289 copy
SMILES
C1=CC=C(C=C1)/C=C/CN2C=C(C=N2)/C=C/C(=O)NC3=C(C=C(C=C3)F)N copy
InChI
InChI=1S/C21H19FN4O/c22-18-9-10-20(19(23)13-18)25-21(27)11-8-17-14-24-26(15-17)12-4-7-16-5-2-1-3-6-16/h1-11,13-15H,12,23H2,(H,25,27)/b7-4+,11-8+ copy
InChIKey
BLVQHYHDYFTPDV-VCABWLAWSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
27 copy
Aromatic heavy atom count
17 copy
Fraction Csp3
0.05 copy
Rotatable bonds
6 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
106.18 copy
TPSA
72.94 copy
LogP / Solubility
WLOGP
3.97 copy
MLOGP
3.51 copy
XLogP3
3.2 copy
Consensus LogP
3.56 copy
Log S (ESOL)
-4.66 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-5.4 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-6.03 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.11 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy